Drawing for ASPIRE RX

USPTO serial 86576192

ASPIRE RX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SAITO, KIM
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ASPIRE RX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew H. Swyers, Esquire

MATTHEW H. SWYERS, ESQUIRE THE TRADEMARK COMPANY344 MAPLE AVE W PMB 151VIENNA, VA 22180-5612UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Offering business management assistance in the establishment and/or operation of pharmaciesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 17, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 16, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 14, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 19, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 19, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 30, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 14, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 10, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 9, 2016RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Sep 4, 2015GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 4, 2015GNSLLETTER OF SUSPENSION E-MAILED—
Sep 4, 2015CNSLSUSPENSION LETTER WRITTEN—
Sep 3, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 3, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 27, 2015ALIEASSIGNED TO LIE—
Aug 12, 2015ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jun 28, 2015GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 28, 2015GNSLLETTER OF SUSPENSION E-MAILED—
Jun 28, 2015CNSLSUSPENSION LETTER WRITTEN—
Jun 28, 2015DOCKASSIGNED TO EXAMINER—
May 5, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 5, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 3, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 28, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance